Elim Biopharmaceuticals Inc - Company Review
Elim Biopharmaceuticals Inc - Company ReviewSummary
Elim Biopharmaceuticals Inc (Elim) is a life science service company that offers cancer sequencing kits and DNA library preparation kits. The company’s DNA library preparation kits provide DNA library construction for next generation sequencing; and cancer sequencing kits offers target enrichment solution for NextGen cancer sequencing. It offers services such as cancer sequencing, bioanalytical and mass spec services, next gen sequencing, peptide synthesis, oligo synthesis, DNA sequencing, and DNA purification. Elim serves biotechnology, pharmaceutical and medical communities. The company markets its products through a network of distributors in the US. Elim is headquartered in Hayward, California, the US.
This comprehensive company report of Elim Biopharmaceuticals Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.